RenovoRx RNXT
NASDAQ RNXT
$1.22 +0.04 (+3.39%)
At close: Nov 11, 2026 · 4:00 PM EST

RenovoRx (RNXT) Change in Other Operating Liabilities (2023 - 2024)

Updated

RenovoRx's Change in Other Operating Liabilities came in at $128,000 for Q2 2024.

Analysis

RenovoRx (RNXT) Change in Other Operating Liabilities (2023 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Liabilities Change (Qtr)
1 Thermo Fisher Scientific 266.22 Bn 242.86 Bn 5.13 Bn -
2 Abbott Laboratories 191.31 Bn 165.77 Bn 7.39 Bn -
3 Danaher 166.16 Bn 145.82 Bn 3.84 Bn -
4 Intuitive Surgical 155.98 Bn 136.40 Bn 2.08 Bn 602.40 Mn
5 Medtronic 130.05 Bn 96.18 Bn 6.34 Bn -
6 Stryker 123.40 Bn 109.59 Bn 4.25 Bn -
7 Boston Scientific 64.81 Bn 60.48 Bn 3.43 Bn -
8 Edwards Lifesciences 59.87 Bn 43.18 Bn 1.35 Bn -
9 Medline 53.84 Bn 50.96 Bn 1.93 Bn 7.00 Mn
10 RenovoRx 56.86 Mn 17.54 Mn 878,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 128,000.00
Mar 31, 2024 -27,000.00
Sep 30, 2023 -5,000.00
Jun 30, 2023 210,000.00
Mar 31, 2023 -246,000.00
API Access

RenovoRx Change in Other Operating Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-other-operating-liabilities&ticker=RNXT&period=max&api_key=YOUR_API_KEY